23.07.25
Huningue, France – Firalis Molecular Precision (FMP) announces that its EXOPROD project – “EXcellence Opérationnelle du nouveau site de PROduction” in Huningue – is receiving financial support from the European Union (EU) through the “Fonds pour une Transition Juste” (FTJ) program.
The FTJ is one of the main tools available to the EU to support regions in their transition to climate neutrality by 2050. It will facilitate the implementation of the European Green Deal, which aims to make the European Union climate neutral by 2050.
With a total budget of €2,391,734.54, the project is receiving a European grant of €400,000, which will support a structural investment program for the future of FMP.
EXOPROD aims to equip our new industrial site with innovative, automated, and sustainable production facilities. This project addresses several strategic challenges: relocating industrial activities, supporting the upskilling of our teams in imported technologies, improving our industrial performance, and reducing the environmental footprint of our activities.
This European funding is part of an ambitious industrial transformation initiative, in line with the FTJ’s objectives: to promote a fair and equitable transition for the regions most exposed to economic and ecological change.
Through EXOPROD, Firalis Molecular Precision is strengthening its local presence and actively contributing to economic development and the creation of qualified jobs in the Grand Est region.
Firalis Molecular Precision would like to thank the European Union for its trust, as well as the institutional players who are supporting us in this dynamic of responsible and sustainable growth.
About Firalis Molecular Precision
Firalis Molecular Precision (FMP) is a fast-growing CRO & CDMO, providing advanced and tailored BioAnalytical Testing services to the Life Sciences sector, based in Huningue, France and in Cambridge, USA.
FMP’s team leverages its extensive scientific expertise and cutting-edge in-house platforms to provide a range of bioanalytical services, namely sample storage and management, multi-omics analysis, data analysis and interpretation, assay development and production – delivering high-quality data to support you along the entire drug development process.
FMP’s mission is to provide healthcare professionals, researchers and biopharmaceutical organizations with the solutions they need to make progress towards better patient care and a more personalized medicine.
About Région Grand Est
The Grand Est Region is a key player in economic development and energy transition in northeastern France. Actively supporting industrial sectors, innovation, training, and employment, the Region plays a leading role in managing and deploying European funds—particularly the Fonds pour une Transition Juste (FTJ). Through this fund, the Region helps implement concrete projects aimed at reducing reliance on fossil fuels, anticipating industrial and social transitions, and promoting balanced, inclusive regional development.
Latest posts
